Skip to main content

Abacavir Sulfate

NDC 51079-204 · Mylan Institutional Inc.

Generic nameabacavir sulfate
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ABACAVIR SULFATE
Strength300 mg/1
Pharmacologic classCytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
Marketing categoryANDA

Packages

51079-204-06 — 50 BLISTER PACK in 1 CARTON (51079-204-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-204-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0904-6874 — Abacavir, 31722-557 — Abacavir, 31722-562 — Abacavir, 31722-838 — ABACAVIR and LAMIVUDINE, 33342-440 — Abacavir and Lamivudine, 42385-962 — Abacavir and Lamivudine, 48433-001 — abacavir sulfate, 49702-222 — abacavir sulfate, 49702-231 — abacavir sulfate, dolutegravir sodium, lamivudine, 50268-049 — Abacavir, 64980-405 — Abacavir Sulfate, 65862-073 — Abacavir, 65862-089 — Abacavir Sulfate, 65862-335 — Abacavir and Lamivudine, 67046-1602 — Abacavir, 68084-021 — Abacavir, 68180-286 — ABACAVIR , LAMIVUDINE AND ZIDOVUDINE, 68180-288 — Abacavir and Lamivudine, 69097-362 — Abacavir and lamivudine, 69097-514 — Abacavir, +2 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels